Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/123573
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Loss of PUMA (BBC3) does not prevent thrombocytopenia caused by the loss of BCL-XL (BCL2L1)
Author: Delbridge, A.
Chappaz, S.
Ritchie, M.
Kile, B.
Strasser, A.
Grabow, S.
Citation: British Journal of Haematology, 2016; 174(6):962-969
Publisher: Wiley
Issue Date: 2016
ISSN: 0007-1048
1365-2141
Statement of
Responsibility: 
Alex R. D. Delbridge, Stephane Chappaz, Matthew E. Ritchie, Benjamin T. Kile Andreas Strasser, Stephanie Grabow
Abstract: Apoptosis is required to maintain tissue homeostasis in multicellular organisms. Platelets, the anucleate cells that are essential for blood clotting, are a prime example. Their brief life span in the circulation is regulated by the intrinsic apoptosis pathway. Pro-survival BCL-XL (also termed BCL2L1) is essential for platelet viability. It functions to restrain the pro-apoptotic BCL-2 family members BAK (also termed BAK1) and BAX, the essential mediators of intrinsic apoptosis. Genetic deletion or pharmacological inhibition of BCL-XL results in thrombocytopenia. Conversely, deletion of BAK in platelets doubles their circulating life span. However, what triggers platelet apoptosis in vivo remains unclear. The pro-apoptotic BH3-only proteins are essential for initiating apoptosis in nucleated cells, and there is some evidence to suggest they also play a role in platelet biology. We investigated whether PUMA (also termed BBC3), a potent BH3-only protein that can inhibit all pro-survival BCL-2 family members as well as directly activate BAX, regulates the death of platelets. Surprisingly, loss of PUMA had no impact on the loss of platelets caused by loss of BCL-XL. It therefore remains to be established whether other BH3-only proteins play a critical role in induction of apoptosis in platelets or whether their death is controlled solely by the interactions between BCL-XL with BAK and BAX.
Keywords: Apoptosis; platelets; thrombocytopenia; therapy; cell biology
Rights: © 2016 John Wiley & Sons Ltd.
RMID: 1000001808
DOI: 10.1111/bjh.14155
Grant ID: http://purl.org/au-research/grants/nhmrc/575535
http://purl.org/au-research/grants/nhmrc/1016701
http://purl.org/au-research/grants/nhmrc/1016647
http://purl.org/au-research/grants/nhmrc/1020363
http://purl.org/au-research/grants/nhmrc/1063008
http://purl.org/au-research/grants/nhmrc/361646
Appears in Collections:Medical Sciences publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.